Skip to content

The effect of eye shield and ear muffs on the intensity of venous blood sampling pain in preterm neonates

The Effect of Using Eye Shield and Ear Muffs on the Intensity of pain During Venous Blood sampling in Preterm Neonates

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200913048704N1
Enrollment
148
Registered
2020-10-27
Start date
2019-11-24
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensity of pain During Venous Blood sampling in Preterm Neonates.

Interventions

Intervention 1: "Intervention Group1: Eye shield group: Infants who receive eye shield from 15 minutes before injection to 15 minutes after injection". Intervention 2: Control group: infants that does

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 28 Days

Inclusion criteria

Inclusion criteria: Premature infants with a gestational age of 32 to 37 weeks Physiological stability of cardio respiratory (percentage of oxygen saturation above 88%, heart rate between 120 to 160, breath rates between 40 to 60 times per minute No congenital or genetic abnormalities Non use of drugs, antidepressants and anticonvulsants by the mother during pregnancy Not receiving anesthesia and anesthesia drugs Lack of intubation 5 minutes, Apgar score above 7

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intensity of pain during venous blood sampling in preterm infants. Timepoint: 15 minutes before, during and 15 minutes after blood sampling. Method of measurement: Neonatal Infant Pain Scale (NIPS).

Secondary

MeasureTime frame
Infant heart rate changes 15 minutes before, during and 15 minutes after intravenous sampling. Timepoint: 15 minutes before, during and 15 minutes after intravenous sampling. Method of measurement: Cardiorespiratory monitoring device.;Changes in infant respiration rate 15 minutes before, during and 15 minutes after intravenous sampling. Timepoint: 15 minutes before, during and 15 minutes after intravenous sampling. Method of measurement: Cardiorespiratory monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Zabihi

Babol University of Medical Sciences

zabihi_alii@yahoo.com+98 11 3219 0595

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026